These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29193788)

  • 21. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging.
    Fabi SG; Goldman MP
    J Drugs Dermatol; 2013 Mar; 12(3):S32-7. PubMed ID: 23545931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Clinical Anti-Ageing Comparative Study of 0.3 and 0.5% Retinol Serums: A Clinically Controlled Trial.
    Zasada M; Budzisz E; Erkiert-Polguj A
    Skin Pharmacol Physiol; 2020; 33(2):102-116. PubMed ID: 32428912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An effective hydroquinone alternative for topical skin lightening.
    Draelos ZD; Deliencourt-Godefroy G; Lopes L
    J Cosmet Dermatol; 2020 Dec; 19(12):3258-3261. PubMed ID: 33098161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of hydroquinone-free skin-lightening cream for photoaging.
    Dreher F; Draelos ZD; Gold MH; Goldman MP; Fabi SG; Puissegur Lupo ML
    J Cosmet Dermatol; 2013 Mar; 12(1):12-7. PubMed ID: 23438137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.
    Hakozaki T; Minwalla L; Zhuang J; Chhoa M; Matsubara A; Miyamoto K; Greatens A; Hillebrand GG; Bissett DL; Boissy RE
    Br J Dermatol; 2002 Jul; 147(1):20-31. PubMed ID: 12100180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of skin-lightening agents.
    Rendon MI; Gaviria JI
    Dermatol Surg; 2005 Jul; 31(7 Pt 2):886-9; discussion 889. PubMed ID: 16029683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
    Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
    Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of systemic treatments for skin lightening.
    Juhasz MLW; Levin MK
    J Cosmet Dermatol; 2018 Dec; 17(6):1144-1157. PubMed ID: 30133125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical benefit of a multimodal topical approach to treating skin dyspigmentation.
    Draelos ZD; Diaz I
    J Cosmet Dermatol; 2023 Jun; 22(6):1799-1804. PubMed ID: 37102219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical treatment of hyperpigmentation disorders.
    Rendon M; Horwitz S
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S153-8. PubMed ID: 23522631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the safety and efficacy of the dual wavelength picosecond laser for the treatment of benign pigmented lesions in Asians.
    Kung KY; Shek SY; Yeung CK; Chan HH
    Lasers Surg Med; 2019 Jan; 51(1):14-22. PubMed ID: 30357871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unraveling the patterns of subclinical pheomelanin-enriched facial hyperpigmentation: effect of depigmenting agents.
    Hermanns JF; Petit L; Martalo O; Piérard-Franchimont C; Cauwenbergh G; Piérard GE
    Dermatology; 2000; 201(2):118-22. PubMed ID: 11053913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development, Characterization and Pharmacological Evaluation of Antiblemish Cream Containing Herbal Oils.
    Krishnaraj S; Mahadevappa K; Narayanaswamy RM; Kamnoore D; Lingutla R; Ghosh T
    Recent Pat Drug Deliv Formul; 2020; 14(3):223-232. PubMed ID: 32479252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders.
    Zhu W; Gao J
    J Investig Dermatol Symp Proc; 2008 Apr; 13(1):20-4. PubMed ID: 18369335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and instrumental evaluation of the efficacy of a new depigmenting agent containing a combination of a retinoid, a phenolic agent and an antioxidant for the treatment of solar lentigines.
    Cameli N; Abril E; Agozzino M; Mariano M
    Dermatology; 2015; 230(4):360-6. PubMed ID: 25871836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Circadian-based Antioxidants Plus a Comprehensive Brightener in Skin of Color Patients With Hyperpigmentation.
    Desai S; Manry S; Makino E; Mehta R
    J Drugs Dermatol; 2022 Apr; 21(4):376-380. PubMed ID: 35389588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New topical tranexamic acid derivative for the improvement of hyperpigmentation and inflammation in the sun-damaged skin.
    da Silva Souza ID; Lampe L; Winn D
    J Cosmet Dermatol; 2021 Feb; 20(2):561-565. PubMed ID: 32588531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The assessment of the effect of a cosmetic product brightening the skin of people with discolorations of different etiology.
    Zasada M; Debowska R; Pasikowska M; Budzisz E
    J Cosmet Dermatol; 2016 Dec; 15(4):493-502. PubMed ID: 27349716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of the effect of a topical product containing C-xyloside and blueberry extract on the appearance of type II diabetic skin.
    Draelos ZD; Yatskayer M; Raab S; Oresajo C
    J Cosmet Dermatol; 2009 Jun; 8(2):147-51. PubMed ID: 19527341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.